Apolipoprotein A-IV inhibits experimental colitis
The antiatherogenic properties of apoA-IV suggest that this protein may act as an anti-inflammatory agent. We examined this possibility in a mouse model of acute colitis. Mice consumed 3% dextran sulfate sodium (DSS) in their drinking water for 7 days, with or without daily intraperitoneal injection...
Salvato in:
| Pubblicato in: | J Clin Invest |
|---|---|
| Autori principali: | , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Clinical Investigation
2004
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC450164/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15254593/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI21233 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|